A validated stability-indicating HPLC method for determination of varenicline in its bulk and tablets

Chemistry Central Journal

Volumn 5, Issue 1, 2011, Pages

  Kadi, Adnan A ^a   Mohamed, Mostafa S ^a   Kassem, Mohamed G ^a   Darwish, Ibrahim A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958253242     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-5-30     Document Type: Article

References (14)

1. Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley III FD, Williams KE. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacol 2007, 52:985-994.
2. Dani JA, De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 2001, 70:439-446. 10.1016/S0091-3057(01)00652-9, 11796143.
3. Picciotto MR, Zoli M, Rimondini R, Léna C, Marubio LM, Pich EM, Fuxe K, Changeux JP. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998, 391:173-177. 10.1038/34413, 9428762.
4. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, Lester HA. Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 2004, 306:1029-1032. 10.1126/science.1099420, 15528443.
5. Zieler-Brown L, Kyle J. Oral varenicline for smoking cessation. Ann Pharmacother 2007, 41:95-99.
6. Chantix Package Insert. 2008, New York, NY: Pfizer Inc, Chantix.
7. Ahuja S, Alsante KM. Handbook of Isolation and Characterization of Impurities in Pharmaceuticals 2003, Academic Press, San Diego.
8. Ahuja S. Impurities Evaluation of Pharmaceuticals 1998, Marcel Dekker, Inc., New York.
9. FDA Guidance for Industry: Impurities in Drug Product, Draft guidance. 1998, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), FDA.
10. Grimm W, Carstensen JT, Rhodes CT, . Eds Drug Stability, Principles and Practices 2002, 520. Marcel Dekker, Inc., New York, Eds.
11. Khan H, Ali M, Ahuja A, Ali J. Stability Testing of Pharmaceutical Products - Comparison of Stability Testing Guidelines. Current Pharm. Anal 2010, 6:142-150.
12. ICH Guidance for Industry Q1A (R2): Stability Testing of New Drug Substances and Products 2000, IFPMA, Geneva, ICH Guidance for Industry.
13. Satheesh B, Kumarpulluru S, Raghavan V, Saravanan D. UPLC separation and quantification of related substances of varenicline tartarate tablet. Acta Chromatographica 2010, 22:207-218.
14. ICH Guideline Q2 (R1): Validation of Analytical Procedure: Text and Methodology. 2005, ICH, London, ICH Guideline.